CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 26,921 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 13,461 shares (grant or award)
- 4 Grant or award Director acquired 60,324 shares (grant or award)
- 4 Grant or award Director acquired 60,324 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 60,324 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 75,000 shares (grant or award)
- 4 Grant or award Director acquired 70,822 shares (grant or award)
- 4 Grant or award Director acquired 5,384 shares (grant or award)
- 4 Grant or award Director acquired 5,384 shares (grant or award)
- 4 Grant or award Director acquired 5,384 shares (grant or award)
- 4/A Open-market buy Market maker/broker-dealer bought 0 shares
- 3/A Insider 3/A
- 4 Open-market buy 10% owner bought 3,715 shares at $0.55 ($2,052)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 9 · 174 filings